Affirm Underweight with 25% single-tranche trim and mechanical $405/$298 exit triggers; adopt neutral put spread hedge
Reject full SELL (six-iteration track record proves 0.5-1.5% alpha ceiling with systematic floor-bid forfeiture); reject $395.62 stop (structurally guaranteed failure above 200 SMA in 1.85-beta name with $55 gap capacity); reject Aggressive's tactical short overlay (1.85 beta + four binary catalysts = asymmetric squeeze risk); adopt Neutral's defined-risk put spread for convexity without tail risk; mechanical $405/≥1.3x volume upgrade trigger tightens architecture per 09-24 mandate.
| Position | Action |
|---|---|
| Consensus-bearish without binding catalyst | 25% trim as single tranche (vs. prior 30% and trader's 50-70%) |
| Residual position hedging | Long $320/short $285 put spread at ≤2% of residual, 4-5 month tenor |
Tesla is a vertically integrated AI, energy, and mobility platform compounding optionality at a pace no peer can match, and the current price action represents base-building after a deep correction rather than distribution—a pullback to $348-352 creates an asymmetric 5:1 reward-to-risk entry.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | $348.25 | bullish |
| close_200_sma | $395.62 | bearish |
| close_10_ema | $371.07 | neutral |
| macd | +6.36 | bullish |
| macdh | 1.08 | bearish |
| rsi | 55.31 | neutral |
| boll_ub | $383.91 | bearish |
| atr | $12.73 | neutral |
Support: 365.68 · 348.25 · 347.46 | Resistance: 395.62 · 386.83 · 383.91
TSLA exhibits mixed technical signals following a bearish intraday reversal that saw the stock reject at the Bollinger Upper Band ($383.91) and close near the day's low at $372.11 on elevated volume of 44.75M shares. The medium-term trend is constructive with price reclaiming the 50 SMA ($348.25) by approximately 6.8%, but the long-term outlook remains bearish as the 200 SMA ($395.62) sits ~6.3% overhead as major resistance. Short-term momentum is decelerating, evidenced by MACD histogram compression from 1.70 to 1.08 and RSI cooling from 60.59 to 55.31, suggesting the path of least resistance is sideways-to-down toward the $365–$348 support zone before the next directional move.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $350 close with volume
Then: Add to Underweight
Margin compression is a feature, not a bug—Tesla is in reinvestment mode like Amazon 2012-2017
↩ rebuts: “Bear thesis that margin compression signals structural deterioration”
EV: +6.2% (to $395 target, 200 SMA)
TSLA is fundamentally deteriorating with an indefensible 338x trailing P/E, and every leg of the bull thesis is built on sand—the recovery is bearish distribution, not base-building.
· concedes: Not calling a top here; Concedes Tesla has balance sheet strength; Semi launch is 'genuinely positive'; FSD data flywheel is real; Megapack dominance is true; The fortress balance sheet is real—it prevents catastrophic downside
→ vs conservative: Being patient with a 338x trailing P/E is analytical paralysis that turns the multiple into permanent capital destruction; when valuation is this indefensible AND the story is detached from delivery, patience is just slowly bleeding out
→ vs neutral: HOLD is a hidden long bet masquerading as prudence — saying 'hold and see what happens' is a de facto long position with no catalyst justification and maximum downside convexity in the worst macro regime for high-beta long-duration names in almost two decades
→ vs neutral: Semi launch headlines, Optimus commercialization talk, and Musk at Trump-Xi dinner are narrative boosters already discounted by Polymarket data; the market isn't buying the delivery story, so why should we
Market Cap
~$1.47T
Beta
1.845
Diluted Shares Outstanding
~3.54B
P/E (TTM)
338.28
Forward P/E
169.35
PEG Ratio
4.52
P/B
16.92
EPS (TTM)
$1.10
Forward EPS
$2.20
52-Week High
$498.83
52-Week Low
$297.38
50-Day MA
$348.63
200-Day MA
$395.96
Book Value
$21.99
Q2 2026 Revenue
$28,236M
Q2 2026 Gross Profit
$4,751M
Q2 2026 Operating Income
$398M
Q2 2026 Net Income
$1,114M
Q2 2026 Diluted EPS
$0.32
Q1 2026 Revenue
$22,387M
Q4 2025 Revenue
$24,901M
Q3 2025 Revenue
$28,095M
Q2 2025 Revenue
$22,496M
2025 Revenue
$94,827M
2024 Revenue
$97,690M
2023 Revenue
$96,773M
2022 Revenue
$81,462M
2025 Gross Profit
$17,094M
2024 Gross Profit
$17,450M
2023 Gross Profit
$17,660M
2022 Gross Profit
$20,853M
2025 Operating Income
$4,849M
2024 Operating Income
$7,760M
2023 Operating Income
$8,891M
2022 Operating Income
$13,832M
2025 EBITDA
$11,764M
2024 EBITDA
$14,708M
2023 EBITDA
$14,796M
2022 EBITDA
$17,657M
2025 Net Income
$3,794M
2024 Net Income
$7,130M
2023 Net Income
$14,999M
2022 Net Income
$12,583M
2025 Diluted EPS
$1.08
2024 Diluted EPS
$2.04
2023 Diluted EPS
$4.31
2022 Diluted EPS
$3.62
Q2 2026 Total Assets
$148,524M
Q1 2026 Total Assets
$143,724M
Q4 2025 Total Assets
$137,806M
Q4 2024 Total Assets
$122,070M
Q2 2026 Cash & ST Investments
$43,524M
Q1 2026 Cash & ST Investments
$44,743M
Q4 2025 Cash & ST Investments
$44,059M
Q4 2024 Cash & ST Investments
$36,563M
Q2 2026 Total Debt
$16,080M
Q1 2026 Total Debt
$15,890M
Q4 2025 Total Debt
$14,719M
Q4 2024 Total Debt
$13,623M
Q2 2026 Stockholders Equity
$86,858M
Q1 2026 Stockholders Equity
$84,116M
Q4 2025 Stockholders Equity
$82,137M
Q4 2024 Stockholders Equity
$72,913M
Q2 2026 Working Capital
$33,333M
Q1 2026 Working Capital
$35,610M
Q4 2025 Working Capital
$36,928M
Q4 2024 Working Capital
$29,539M
Current Ratio
1.94
Debt/Equity
18.37%
Q2 2026 Inventory
$13.75B
Q2 2026 Finished Goods
$5.93B
Q2 2026 Gross PPE
$84.0B
2025 Operating Cash Flow
$14,747M
2024 Operating Cash Flow
$14,923M
2023 Operating Cash Flow
$13,256M
2022 Operating Cash Flow
$14,724M
2025 CapEx
($8,527M)
2024 CapEx
($11,342M)
2023 CapEx
($8,899M)
2022 CapEx
($7,172M)
2025 Free Cash Flow
$6,220M
2024 Free Cash Flow
$3,581M
2023 Free Cash Flow
$4,357M
2022 Free Cash Flow
$7,552M
Q2 2026 OCF
$4,697M
Q2 2026 CapEx
($5,796M)
Q2 2026 FCF
($1,099M)
Q1 2026 OCF
$3,937M
Q1 2026 CapEx
($2,493M)
Q1 2026 FCF
$1,444M
Q4 2025 OCF
$3,813M
Q4 2025 CapEx
($2,393M)
Q4 2025 FCF
$1,420M
Q3 2025 OCF
$6,238M
Q3 2025 CapEx
($2,248M)
Q3 2025 FCF
$3,990M
Q2 2025 OCF
$2,540M
Q2 2025 CapEx
($2,394M)
Q2 2025 FCF
$146M
TTM Free Cash Flow
$4.84B
2025 Stock-Based Compensation
~$2.8B
Q2 2026 Stock-Based Compensation
~$1.15B
Profit Margin
3.67%
Operating Margin
1.41%
ROE
4.67%
ROA
1.93%
TTM Revenue
~$103.6B
TTM Gross Profit
~$19.5B
TTM EBITDA
~$10.8B
TTM Net Income
~$3.81B
Net Cash Position
~$27.4B
Long-Term Debt
$7.7B
Strengths
Concerns
TSLA exhibits extreme fundamental deterioration: operating margin has collapsed to 1.4% (from 17% in 2022) and net income has fallen 75% from its 2023 peak, yet the stock trades at a 338x trailing P/E reflecting investor pricing for AI/autonomy optionality. The balance sheet remains fortress-like with $27.4B in net cash, providing funding capacity for the aggressive AI/robotics reinvestment (R&D up 50% YoY, CapEx spiking to $5.8B in Q2 2026 alone) that is suppressing near-term profitability. The valuation leaves no room for execution missteps; traders should monitor auto gross margin trajectory, Q3 deliveries, FCF sustainability, and FSD/robotaxi commercial milestones as the primary fundamental catalysts.
Macro: Sharp bond-market re-pricing is the dominant macro story. The U.S. 10-year Treasury yield hit its highest level since 2007, with the 30-year yield at its highest since 2004. Markets are pricing additional Fed rate hikes (90% odds of another hike in 2026), not cuts — a notable regime shift. Mortgage rates are creeping toward 7.5%, signaling real-economy tightening. Prediction markets show 'No Fed rate cuts in 2026' at 96% and '2+ Fed hikes' at 52% (up 19.2pp on the week). Recession odds are modest: U.S. 10%, UK 14%, Japan 4%. Crude oil new all-time highs are given 0% odds by Sept 30 and only 10% by year-end, suggesting the inflation impulse is moderating and yields are driven by fiscal/term-premium dynamics. The equity tape absorbed the duration shock (S&P 500, Dow, and Nasdaq posted weekly gains), but the setup is fragile for long-duration growth names like TSLA.